GC WellBeing affiliate Inibio receives Chinese approval for botulinum toxin 'Inybo'
Predicted impact: Low
Chinese approval for affiliate's botulinum toxin; small relative to parent company's size.
Predicted impact: Low
Chinese approval for affiliate's botulinum toxin; small relative to parent company's size.
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.